SQI Diagnostics signs commercial contract with global biotech

SQI Diagnostics signs commercial contract with global biotech


SQI Diagnostics Inc. has signed an agreement to commercialize a custom multiplexed assay for a Waltham, MA-based global biotechnology company's blood disorder drug program. As part of the agreement, SQI will provide sample analysis and data reporting services on human study samples using a custom-developed test unique to the unnamed customers biologic therapeutic.



from Biotech News